Inside Immatics / Scientific Advisory Board

Scientific Advisory Board

Immatics’ Scientific Advisory Board is made up of pioneering scientists with
expertise ranging across areas such as immuno-oncology, adoptive cell therapies,
clinical oncology and cancer biology.

Cassian Yee, M.D.

MD Anderson Cancer Center US
Christoph Huber, Ph.D.

Johannes Gutenberg University Germany
Gwendolyn Binder, Ph.D.

Cabaletta Bio US
Hans-Georg Rammensee, Ph.D.

Eberhard Karls University Germany
Hidde Ploegh, Ph.D.

Boston Children’s Hospital US
Patrick Hwu, M.D.

The University of Texas MD Anderson Cancer Center US
Roland Kontermann, Ph.D.

University of Stuttgart Germany

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close